Consortium led by Nordic Capital, Permira to acquire Bavarian Nordic
July 28 (Reuters) - Vaccine maker Bavarian Nordic BAVA.CO said on Monday it had entered into an agreement with Innosera ApS, a newly formed company controlled by a consortium led by Nordic Capital and Permira, which is to make an all-cash takeover offer of 233 Danish crowns ($36.59) per share for the Danish company that recommends investors to accept it. ($1 = 6.3677 Danish crowns) (Reporting by Izabela Niemiec in Gdansk, editing by Milla Nissi-Prussak) ((Izabela.niemiec@thomsonreuters.com))
Recent news on Bavarian Nordic A/S
See all newsBrief: Bavarian Nordic Gets Smallpox/Mpox Vaccine Supply Contract
Brief: Bavarian Nordic Secures Additional Government Contract For The Supply Of Smallpox/Mpox Vaccine
Brief: Bavarian Nordic Launches Final Tranche Of Buy-Back Program
Bavarian Nordic falls as high costs, lower vaccine sales hit Q1 results
Bavarian Nordic Q1 revenue falls as Public Preparedness unit sales decline